Zhang Liqiao, Yang Chunyan, Dong Wei, Du Yaqing, Wang Ruiping
Department of Obstetrics, Xingtai People's Hospital Xingtai 054001, Hebei, China.
Department of TCM Internal Medicine, Xingtai People's Hospital Xingtai 054001, Hebei, China.
Am J Transl Res. 2021 Nov 15;13(11):12868-12874. eCollection 2021.
To investigate the effects of Fu Fang Yi Mu Cao (FFYMC) capsules combined with Yiqi Xiaoyu (YX) decoction on persistent lochia after birth.
In this retrospective analysis, 120 patients with lochia treated in our hospital from January 2014 to October 2020 were enrolled as study subjects. Sixty of each were randomly allocated into the study group (60 cases, treated with FFYMC capsules and YX decoction) and the control group (60 cases, treated with YX decoction). The two groups were compared in terms of efficacy, volume of lochia and changes in Traditional Chinese Medicine Syndrome Score (TCMSS) before and after intervention, and the incidence of adverse reactions.
(1) The total effective rate in the study group was 100.00%, which was significantly higher than that in the control group (P<0.05); (2) The difference in volume of lochia between two groups before the intervention was not statistically significant (P>0.05), and was significantly lower in the study group than in the control group at day 4 and day 7 of the intervention (P<0.05); (3) The difference in TCMSS between two groups before the treatment was not statistically significant (P>0.05). TCMSS was lower in the study group than in the control group after treatment (P<0.05); (4) The decreased height of uterine fundus in the study group was higher than that in the control group at 5 d after treatment (P<0.05); (5) The plasma viscosity in the study group was significantly lower than that in the control group (P<0.05); (6) The total incidence of adverse reactions in the study group was 8.33%, which was not significantly different from the control group which was 11.67% (P>0.05).
FFYMC capsule and YX decoction could improve the treatment effect for primiparas with lochia in terms of reducing volume of lochia and improving clinical symptoms with high safety.
探讨复方益母草胶囊联合益气消瘀汤治疗产后恶露不绝的效果。
本回顾性分析选取2014年1月至2020年10月在我院接受恶露治疗的120例患者作为研究对象。将其随机分为研究组(60例,采用复方益母草胶囊联合益气消瘀汤治疗)和对照组(60例,采用益气消瘀汤治疗)。比较两组的疗效、恶露量、干预前后中医证候积分(TCMSS)变化以及不良反应发生率。
(1)研究组总有效率为100.00%,显著高于对照组(P<0.05);(2)干预前两组恶露量差异无统计学意义(P>0.05),干预第4天和第7天研究组恶露量显著低于对照组(P<0.05);(3)治疗前两组TCMSS差异无统计学意义(P>0.05),治疗后研究组TCMSS低于对照组(P<0.05);(4)治疗后5天研究组子宫底下降高度高于对照组(P<0.05);(5)研究组血浆黏度显著低于对照组(P<0.05);(6)研究组不良反应总发生率为8.33%,与对照组的11.67%差异无统计学意义(P>0.05)。
复方益母草胶囊联合益气消瘀汤可提高初产妇恶露不绝的治疗效果,在减少恶露量、改善临床症状方面效果显著,且安全性高。